pharmaceuticals
Revolutionizing Clinical Trials: How the FDA is Accelerating Processes with AI Innovation
The FDA is taking exciting steps to improve clinical trials. Recently, they started reviewing data in real-time from trials run ... Read more
Erasca Unveils Promising Preliminary Results for Innovative Pancreatic and Lung Cancer Therapy
Erasca recently announced exciting results about its RAS-targeting pill, ERAS-0015. In tests, the drug helped shrink tumors in 40% of ... Read more
Intellia Therapeutics’ CRISPR Breakthrough: Pivotal Trial Confirms Successful Treatment Results
Intellia Therapeutics is making waves in the world of gene editing. Their new treatment for hereditary angioedema, a condition that ... Read more
UnitedHealth Surpasses Quarterly Expectations and Raises Profit Outlook Amid Rising Medical Costs
UnitedHealth Group recently announced impressive first-quarter earnings, surpassing expectations and raising its profit outlook for 2026. The company, which is ... Read more
How Eli Lilly’s $3.25 Billion Acquisition of Kelonia Therapeutics Marks a Turning Point in the Startup’s Challenging Journey
Eli Lilly has announced a significant move: they are acquiring Kelonia Therapeutics for $3.25 billion. This small biotech firm specializes ... Read more
Congress Confronts a Full Plate: What’s on the Agenda for Health Care Reform?
Trump removed an AI-generated image of himself resembling Jesus after conservative Christians expressed their outrage. He explained to reporters that ... Read more
Eli Lilly’s Breakthrough Obesity Drug Retatrutide Triumphs in First Late-Stage Diabetes Trial: What It Means for You
Eli Lilly is making waves with its new obesity drug, retatrutide. Recently, it passed a critical late-stage trial focusing on ... Read more
FDA’s New Move Against UniQure Sparks Controversy: What You Need to Know
During a recent media call organized by the FDA, a senior official spoke about UniQure and its experimental Huntington’s disease ... Read more
Trump’s Controversial Glyphosate Order Sparks MAHA Outrage—How This Could Empower Democrats
In recent news, the Make America Healthy Again (MAHA) movement faces unexpected challenges from the Trump administration. President Trump signed ... Read more
Inside Hims’ Earnings Call: CEO Tackles GLP-1 Compounding Concerns Head-On
In recent times, telehealth company Hims & Hers has sparked discussions about compounded GLP-1 weight loss medications. During a recent ... Read more
